Is metformin safe enough for ageing type 2 diabetic patients?

Diabetes and Metabolism

Volumn 22, Issue 1, 1996, Pages 43-50

  Gregorio, F ^a,b,c   Ambrosi, F ^b,d   Filipponi, P ^b   Manfrini, S ^e,f   Testa, I ^e  

^a E Profili General Hospital   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Anti Diabetic Unit   (Italy)

^d Anti Diabet Units Magione P   (Italy)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^f General Hospital of Senigallia (AN)   (Italy)

Author keywords

ageing; metabolic control; metformin; plasma lactate; Type 2 diabetic patients

Indexed keywords

BIGUANIDE DERIVATIVE; GLIBENCLAMIDE; GLICLAZIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTIC ACID; LOW DENSITY LIPOPROTEIN; METFORMIN; SULFONYLUREA DERIVATIVE; URIC ACID; LIPID;

AGED; AGING; ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; LACTATE BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; URIC ACID BLOOD LEVEL; WEIGHT REDUCTION; CLINICAL TRIAL; DIABETES CONTROL; DRUG EFFECT; DRUG TOLERABILITY;

AGED; AGED, 80 AND OVER; AGING; ANTHROPOMETRY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; LACTATES; LACTIC ACID; LIPIDS; LIVER FUNCTION TESTS; MALE; METFORMIN; SULFONYLUREA COMPOUNDS;

EID: 0029670480     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Peters AL, Davidson MB. Aging and diabetes. In : Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, eds. "International Textbook of Diabetes Mellitus". J. Wiley & Sons Ltd, 1992, 1104-1128.
2. Morrow LA, Alter JB. Treatment of elderly with diabetes. In : Kahn CR. Weir CG. eds. "Joslin's Diabetes Mellitus", 13th Edition. Lea & Febiger, 1994, 552-559.
3. Stout RW. Diabetes mellitus and old age. In : Pickup J and Williams G. eds. "Textbook of Diabetes". Oxford : Blackwell, 1991, 897-904.
4. Morley JE, Perry III HM. The management of diabetes mellitus in older individuals. Drugs, 1991, 41, 548-565.
5. Sinclair AJ. Initial management of non-insulin-dependent diabetes mellitus in the elderly. In : Finucane P, Sinclair P, eds. "Diabetes in old age". J. Wiley & Sons Ltd, 1995, 181-201.
6. Melander A. Sulphonylureas in the treatment of non-insulin-dependent diabetes. In : Nattrass M, Hale PJ, eds. "Non-insulin-dependent diabetes". Baillière's Clinivzl Endocrinology and Metabolism, 1988, 2, 443-453.
7. Brunetti P. Revisione critica dell'uso degli ipoglicemizzanti orali. II Diabete, 1989, 4, 27-34.
8. Groop LC. Sulfonylureas in NIDDM. Diabetes Care, 1992, 15, 737-754.
9. Gerich JE. Oral hypoglycemic agents. N Rngl J Med. 1989, 321, 1231-1245.
10. Berger W. Incidence of severe side effects during therapy with sulfonylureas and biguanides. Harm Metab Res, 1985, 17 (suppl. 15), 111-115.
11. Gregorio F, Santeusanio F. Le biguanidi : aspetti farmacologici ed impiego clinico. G Ital Diabetol, 1993, 13, 43-60.
12. Hermann LS, Melander A. Biguanides : basic aspects and clinical uses. In : Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, eds. "International Textbook of Diabetes Mellitus". J. Wiley & Sons Ltd, 1992, 773-795.
13. Bailey CJ. Biguanides and NIDDM. Diabetes Care, 1992, 15, 755-784.
14. Hermann LS. Metformin : a review of its pharmacological properties and therapeutic use. Diabete Metab. 1979, 5, 233-245.
15. Filipponi P, Gregorio F. Acidosi lattica. In : Larizza P, Furbetta D. eds. "Compendio di Medicina Interna e Terapia". Padova : Piccin, 1993, 1005-1010.
16. Wiholm BE, Myrhed M. Metformin-associated lactic acidosis in Sweden 1977-1991. Eur J Clin Pharmacol, 1993, 44, 589-591.
17. Vaccaro O, Imperator G, Ferrara A, Palombino R, Riccardi G. General practitioner's management of non-insulin-dependent diabetes mellitus : does it comply with recommended standards ? Diab Nutr Metab, 1994, 7, 123-129.
18. DeFronzo R, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab, 1991, 73, 1294-1301.
19. Couet C, Delarue J, Constans T, Lamisse F. Age-related insulin resistance : a review. Horm Res, 1992, 38, 46-50.
20. Stout R. Ageing and glucose tolerance. In : Finucane P, Sinclair P, eds. "Diabetes in old age". J. Wiley & Sons Ltd, 1995, 21-44.
21. Gregorio F, Ambrosi F, Marchetti P. et al. Low dose metformin in the treatment of type II non-insulin-dependent diabetes : clinical and metabolic evaluations. Acta Diabetol Lat, 1990, 27, 139-155.
22. Higginbottham L, Martin FIR. Double-blind trial of metformin in the therapy of non-ketotic diabetes. Med J Aust, 1979, 2, 154-156.
23. Marchetti P, Gregorio F., et al. Diurnal pattern of plasma metformin concentration and its relation to metabolic effects in type II (non-insulin-dependent) diabetic patients. Diabete Metab, 1990, 16, 473-478.
24. Vauzelle-Kervroedan F, Forhan A, Papoz L. Prévalence régionale du diabète traité par les hypoglycémiants oraux. Diabete Metab, 1993, 19, 291-295.
25. Bruno G, Bargero G, Vuolo A, Pisu E, Pagano G. A population-based prevalence survey of known diabetes mellitus in Northen Italy based upon multiple independent sources of ascertainment. Diabetologia, 1992, 35, 851-856.
26. DiCianni G, Benzi L, et al. A prevalence study of known diabetes mellitus in Tuscany assessed from pharmaceutical prescriptions and other independent sources. Acta Diabetol, 1994, 31, 87-90.
27. Papoz L, Vauzelle F, Vexiau P, Cathelineau G. Pattern of treatment among diabetic patients in France. Diabetes Cure, 1988, 11, 586-591.
28. Knight PV, Semple CG, Kesson CM. The use of metformin in the older patient. J Clin Exp Geront, 1986, 8, 51-58.
29. Josephkutty S, Potter JM. Comparison of tolbutamide and metformin in elderly diabetic patients. Diabetic Med., 1990, 7, 510-514.
30. Clarke BF, Campbell IW. Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet. Br. Med. J., 1977, 2, 1576-1578.
31. Clarke BF, Ducan LJP. Biguanide treatment in the management of insulin-independent (maturity-onset) diabetes : clinical experience with metformin. Res Clin Forums, 1979, 1, 53-63.
32. Hermann LS, Scherstén B, Bitzén PO, Kjellström T, Lindgärde F, Melander A. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. Diabetes Care, 1994, 17, 1100-1109.
33. Chalmers J, Brown IRF, McBain AM, Campbell IW. Metformin : is its use contraindicated in the elderly ? Pract Diabetes, 1992, 9, 51-53.
34. Lalau JD, Vermersch A, Hary L, Andrejak M, Isnard F, Quichaud J. Type 2 diabetes in the elderly : an assessment of metformin (metformin in the elderly). Int J Clin Pharmacol Ther Toxicol, 1990, 28, 329-332.
35. Lindeman RD, Tobin JT, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc, 1985, 33, 278-285.
36. Roy AT, Johnson LE, et al. Renal failure in older people. UCLA Grand Rounds. J Am Geriatr Soc, 1990, 38, 239-253.
37. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men : a cross-sectional and longitudinal study. J Gerontol, 1976, 31, 155-163.
38. Gregorio F, Ambrosi F, Filipponi P, et al. Metformin and haemostatic variables in type II non-insulin-dependent diabetes mellitus. Diab Nutr Metab, 1995, 8, 25-32.
39. Garancini P, Gallus G, Calori G, Formigaro F, Micossi P. Incidence and prevalence rates of diabetes mellitus in Italy from routine data : a methodological assessment. Eur J Epidemiol, 1991, 1, 55-63.
40. Nagi DK, Yudkin JS. Effects of metformin on insulin resistance, risk factors for cardiovascular disease and plasminogen activator inhibitor in NIDDM subjects. Diabetes Care, 1993, 16, 621-629.
41. Giugliano D, Quatraro A, Consoli G, et al. Metformin for obese, insulin-treated diabetic patients : improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol, 1993, 44, 107-112.
42. Wu MS, Johnston P, Sheu WHH, et al. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care, 1990, 13, 1-8.
43. Hollenbeck CB, Johnston P, Varasteh BB, Chen YDI, Reaven GM. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin-dependent diabetes by glucose tolerance test criteria. Diabete Metab, 1991, 17, 483-489.
44. Gregorio F, Ambrosi F, Capodicasa E, Manfrini S, Testa I, Filipponi P. Metformin-sulfonylurea combination therapy : the influence of regional adiposity on the biguanide induced haemostatic improvement. Balance in type II diabetic patients. Ann Experim Clin Med, 1994, 2, 136-145.
45. Descovich G, Montaguti U, Ceredi C, Cocuzza E, Sirtorio CR. Long-term treatment with metforminin a large cohort of hyperlipidemic patients. Artery, 1978, 4, 348-359.
46. Montanari G, Bondioli A, et al. Treatment with low dose metformin in patients with peripheral vascular disease. Pharmacol Res, 1992, 25, 63-73.
47. Chan JCN, Tomlinson B, Critchley JAJH, Cockram CS, Walden RJ. Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients. Diabetes Care, 1993, 16, 1035-1038.
48. Melchionda N, Enzi G, et al. Epidemiology of obesity in the elderly : CNR multicentric study in Italy. Diab Res Clin Pract 1990, 10 (suppl. 1), 11-16.
49. Zavaroni I, Dall'Aglio E, Bruschi F, et al. Effect of age and environmental factors on glucose tolerance and insulin secretion in a worker population. J Am Geriatr Soc, 1986, 34, 271-275.
50. Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AD, Andres R. Age as independent determinant of glucose tolerance. Diabetes. 1991, 40, 44-51.
51. Kohrt WM, Kirwan JP, Staten MA, Bourey RE, King DS, Holloszy JO. Insulin resistance in aging is related to abdominal obesity. Diabetes, 1993, 42, 273-281.
52. Campbell IW, Ducan C, Patton NW, Broadhead T, Tucker GT, Woods HF. The effect of metformin on glycaemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus. Diabetic Med, 1987, 4, 337-341.
53. Pedersen O, Nielsen OH, Bak J, Richelsen B, Beck-Nielsen H. Sorensen NS. The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type II diabetes. Diabetic Med, 1989, 6, 249-256.
54. Jackson RA, Hawa MI, Jaspan JB, et al. Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes, 1987, 36, 632-640.
55. Lebovitz HE. Stepwise and combination drug therapy for the treatment of NIDDM. Diabetes Care, 1994, 12, 1542-1544.